Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Synergy Pharmaceuticals Inc.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Three UMSL graduates among St. Louis Business Journal’s 40 Under 40 Class of 2024
Alums Jessica Cross, Stephanie Korpal and Maggie Rapplean were honored at the annual luncheon at the Chase Park Plaza.
MORE IN Synergy Pharmaceuticals Inc.
LATEST NEWS
- Three UMSL graduates among St. Louis Business Journal’s 40 Under 40 Class of 2024
- Bethany Worrell joins UMSL Department of Music as director of vocal studies
- Eye on UMSL: Level up
- UMSL Tritons weekly rewind
- Fall Music Festival showcases ‘energy and vitality’ of UMSL Department of Music
- Midwest BankCentre CEO Orv Kimbrough speaks on importance of ethical decision-making
- University of Missouri–St. Louis, Greater St. Louis Area Council Scouting finalize partnership to support future students
- Retired Director of Athletics Lori Flanagan selected for induction into Missouri Sports Hall of Fame
- UMSL partners with Girl Scouts of Eastern Missouri to support future students with scholarships
- UMSL partnering with Ziplines Education to drive workforce development with tech-adjacent skills training
